임상개발, 허가, 판매 기술료로 최대 11억유로까지 받을 수 있으며, 상업화 달성에 따라 경상기술료까지 수령 가능하다.
It is possible to receive up to EUR 1.1 billion for clinical development, license, and sales technology fee, and up to regularity technology fee can be received according to commercialization.